A 6-year-old girl from Kerala presents with jaundice, dark urine, and bone pain. She has a history of recurrent transfusions since age 2 years. Physical examination reveals hepatosplenomegaly, frontal bossing, and maxillary prominence. Serum bilirubin is 4.2 mg/dL (indirect), serum ferritin is 2800 ng/mL, and serum creatinine is 1.4 mg/dL (elevated for age). Abdominal ultrasound shows hepatic cirrhosis and pancreatic atrophy. Which complication is most directly responsible for the elevated creatinine?

Explanation

## Complication: Iron-Induced Renal Dysfunction ### Clinical Context This patient with beta-thalassemia major has: - **Chronic transfusion dependence** (since age 2) → iron overload - **Markedly elevated ferritin** (2800 ng/mL; normal <300 ng/mL) - **Elevated creatinine** (1.4 mg/dL) indicating renal impairment - **Hepatic cirrhosis** and **pancreatic atrophy** — classic iron-overload complications **High-Yield:** Iron overload (secondary hemochromatosis) is a major cause of morbidity and mortality in transfusion-dependent thalassemia patients. ### Iron Deposition and Renal Pathology **Key Point:** Iron deposits in the kidneys cause: 1. **Proximal tubular dysfunction** → loss of glucose, amino acids, phosphate (Fanconi syndrome) 2. **Glomerular injury** → proteinuria, reduced GFR 3. **Interstitial fibrosis** → chronic kidney disease **Clinical Pearl:** Iron-induced renal injury in thalassemia typically manifests as: - Tubular dysfunction (low-molecular-weight proteinuria, glycosuria, phosphaturia) - Progressive decline in GFR - Elevated creatinine and reduced eGFR - Usually reversible with iron chelation therapy if caught early ### Why Iron Overload Occurs **Mnemonic: TRANSFUSION IRON LOAD** - **T**ransfusions: each unit of RBCs contains ~250 mg iron - **R**ecurrent: chronic transfusion dependence - **A**ccumulation: no physiologic iron excretion mechanism - **N**o chelation or inadequate chelation - **S**econdary hemochromatosis develops - **F**erritin rises progressively - **U**rinary iron loss is minimal - **S**iderosis affects multiple organs: heart, liver, pancreas, kidneys - **I**ron deposits in renal tubules → dysfunction - **O**rgan failure: cardiac arrhythmias, cirrhosis, diabetes, renal failure - **N**eed for iron chelation (deferoxamine, deferiprone, deferasirox) ### Comparison of Renal Complications in Thalassemia | Mechanism | Presentation | Reversibility | |-----------|--------------|---------------| | **Iron deposition** | Tubular dysfunction, progressive GFR decline | Partially reversible with chelation | | Hemolysis-induced ATN | Acute rise in creatinine, dark urine | Reversible with hydration | | Hyperuricemia | Uric acid crystal precipitation | Reversible with allopurinol | | Hypertension/cirrhosis | Glomerulosclerosis | Usually irreversible | **High-Yield:** The **markedly elevated ferritin (2800 ng/mL)** in a chronically transfused patient is the strongest clue that iron overload is the primary mechanism of renal dysfunction. ### Management **Key Point:** Iron chelation therapy (deferoxamine, deferiprone, or deferasirox) is essential to: - Prevent further iron accumulation - Slow progression of organ damage - Improve renal function if caught early [cite:Robbins 10e Ch 12; Harrison 21e Ch 104]